Is Armata Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSEMKT: ARMP) stock is to Buy ARMP stock.
Out of 1 analyst, 0 (0%) are recommending ARMP as a Strong Buy, 1 (100%) are recommending ARMP as a Buy, 0 (0%) are recommending ARMP as a Hold, 0 (0%) are recommending ARMP as a Sell, and 0 (0%) are recommending ARMP as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year ARMP price target, the average ARMP price target is $7.00, with the highest ARMP stock price forecast at $7.00 and the lowest ARMP stock price forecast at $7.00.
The Wall Street analyst predicted that Armata Pharmaceuticals's share price could reach $7.00 by Dec 19, 2025. The average Armata Pharmaceuticals stock price prediction forecasts a potential upside of 469.11% from the current ARMP share price of $1.23.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.